TABLE 3.
Main findings of arterial dilator function tests
| Group 1 (n = 25) | Group 2 (n = 47) | Group 3 (n = 12) | p | |
|---|---|---|---|---|
| FMD assessment | ||||
| Basal artery diameter (mm) | 3.98 ± 0.70 | 4.09 ± 0.64 | 4.19 ± 0.61 | 0.62 |
| Peak artery diameter (mm) | 4.19 ± 0.75 | 4.29 ± 0.68 | 4.38 ± 0.61 | 0.71 |
| Artery diameter increase (mm) | 0.21 ± 0.09 | 0.20 ± 0.07 | 0.19 ± 0.07 | 0.64 |
| FMD (%) | 5.25 ± 2.0 | 4.95 ± 1.6 | 4.43 ± 1.8 | 0.42 |
| NMD assessment | ||||
| Basal artery diameter (mm) | 4.00 ± 0.71 | 4.11 ± 0.66 | 4.16 ± 0.61 | 0.75 |
| Peak artery diameter (mm) | 4.41 ± 0.77 | 4.45 ± 0.68 | 4.57 ± 0.70 | 0.81 |
| Artery diameter increase (mm) | 0.43 ± 0.11 | 0.36 ± 0.13 | 0.37 ± 0.15 | 0.27 |
| NMD (%) | 10.8 ± 2.3 | 8.98 ± 3.0 | 8.82 ± 3.2 | 0.027 |
Note: Group 1 = patients with normal left ventricle diastolic function; Group 2 = patients with grade I (mild) left ventricle diastolic dysfunction; Group 3 = patients with grade II–III (moderate/severe) left ventricle diastolic dysfunction.
Abbreviations: FMD, flow‐mediated dilation; NMD, nitrate‐mediate dilation.